Houyong Dai
- Co-authors
- Bi‐Cheng LiuKun‐Ling MaRi‐Ning TangLin‐Li LvJie NiYide ZhangQing LiLi Yuan
- Topics
- Chronic Kidney Disease and Diabetes (7 papers)Renal Diseases and Glomerulopathies (5 papers)Connective Tissue Growth Factor Research (3 papers)
- Journals
- PLoS ONEMedicineClinica Chimica Acta
- Partner nations
- ChinaUnited Kingdom
In The Last Decade
Houyong Dai
20 papers receiving 341 citations
Peers
Comparison fields: 5 of 63
- Molecular Biology 147
- Nephrology 107
- Cardiology and Cardiovascular Medicine 74
- Surgery 47
- Immunology 47
Countries citing papers authored by Houyong Dai
This map shows the geographic impact of Houyong Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Houyong Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Houyong Dai more than expected).
Fields of papers citing papers by Houyong Dai
This network shows the impact of papers produced by Houyong Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Houyong Dai. The network helps show where Houyong Dai may publish in the future.
Co-authorship network of co-authors of Houyong Dai
This figure shows the co-authorship network connecting the top 25 collaborators of Houyong Dai. A scholar is included among the top collaborators of Houyong Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Houyong Dai. Houyong Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 8 | |
| 5 | 21 | |
| 6 | 13 | |
| 7 | [Research update of Klotho in kidney injury and repair]. | 1 |
| 8 | 5 | |
| 9 | 1 | |
| 10 | 2 | |
| 11 | 14 | |
| 12 | 13 | |
| 13 | 52 | |
| 14 | 7 | |
| 15 | Inhibition of integrin-linked kinase by angiotensin II receptor antagonist, irbesartan attenuates podocyte injury in diabetic rats. | 12 |
| 16 | 20 | |
| 17 | 31 | |
| 18 | 60 | |
| 19 | 23 | |
| 20 | 47 |
About Houyong Dai
Houyong Dai is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, having authored 20 papers that have together received 342 indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (7 papers), Renal Diseases and Glomerulopathies (5 papers) and Connective Tissue Growth Factor Research (3 papers). The work is most often cited by research in Nephrology (107 citations), Cardiology and Cardiovascular Medicine (74 citations) and Immunology (47 citations). Houyong Dai has collaborated with scholars based in China and United Kingdom. Frequent co-authors include Bi‐Cheng Liu, Kun‐Ling Ma, Ri‐Ning Tang, Lin‐Li Lv, Jie Ni, Yide Zhang, Qing Li, Li Yuan, Min Zheng and Weisheng Peng. Their work appears in journals such as PLoS ONE, Medicine and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.